NCT02178358 2022-02-25A Study of LY2157299 in Participants With Advanced Hepatocellular CarcinomaEli Lilly and CompanyPhase 2 Completed132 enrolled 25 charts
NCT01246986 2021-01-12A Study of LY2157299 in Participants With Hepatocellular CarcinomaEli Lilly and CompanyPhase 2 Completed204 enrolled 27 charts